| Physical activity and mortality in cancer survivors: a systematic review and meta-analysis CM Friedenreich, CR Stone, WY Cheung, SC Hayes JNCI cancer spectrum 4 (1), pkz080, 2020 | 344 | 2020 |
| Comparisons of patient and physician expectations for cancer survivorship care WY Cheung, BA Neville, DB Cameron, EF Cook, CC Earle Journal of Clinical Oncology 27 (15), 2489-2495, 2009 | 314 | 2009 |
| Impact of comorbidity on chemotherapy use and outcomes in solid tumors: a systematic review L Lee, WY Cheung, E Atkinson, MK Krzyzanowska Journal of Clinical Oncology 29 (1), 106-117, 2011 | 272 | 2011 |
| Symptom clusters in patients with advanced cancers WY Cheung, LW Le, C Zimmermann Supportive care in cancer 17, 1223-1230, 2009 | 223 | 2009 |
| Age and gender differences in symptom intensity and symptom clusters among patients with metastatic cancer WY Cheung, LW Le, L Gagliese, C Zimmermann Supportive Care in Cancer 19, 417-423, 2011 | 211 | 2011 |
| The effect of estrogen vs. combined estrogen‐progestogen therapy on the risk of colorectal cancer KJ Lin, WY Cheung, JYC Lai, EL Giovannucci International journal of cancer 130 (2), 419-430, 2012 | 200 | 2012 |
| Adjuvant chemotherapy use and outcomes of patients with high‐risk versus low‐risk stage II colon cancer A Kumar, HF Kennecke, DJ Renouf, HJ Lim, S Gill, R Woods, C Speers, ... Cancer 121 (4), 527-534, 2015 | 171 | 2015 |
| The association of physical and psychological symptom burden with time to death among palliative cancer outpatients WY Cheung, N Barmala, S Zarinehbaf, G Rodin, LW Le, C Zimmermann Journal of pain and symptom management 37 (3), 297-304, 2009 | 135 | 2009 |
| Physician preferences and attitudes regarding different models of cancer survivorship care: a comparison of primary care providers and oncologists WY Cheung, N Aziz, AM Noone, JH Rowland, AL Potosky, JZ Ayanian, ... Journal of Cancer Survivorship 7, 343-354, 2013 | 126 | 2013 |
| Self‐management interventions for cancer survivors: a systematic review and evaluation of intervention content and theories CA Cuthbert, JF Farragher, BR Hemmelgarn, Q Ding, GP McKinnon, ... Psycho‐Oncology 28 (11), 2119-2140, 2019 | 125 | 2019 |
| Phase-specific and lifetime costs of cancer care in Ontario, Canada C de Oliveira, R Pataky, KE Bremner, J Rangrej, KKW Chan, WY Cheung, ... BMC cancer 16, 1-12, 2016 | 123 | 2016 |
| Etiology of delays in the initiation of adjuvant chemotherapy and their impact on outcomes for Stage II and III rectal cancer WY Cheung, BA Neville, CC Earle Diseases of the colon & rectum 52 (6), 1054-1064, 2009 | 113 | 2009 |
| 25 year survival outcomes for squamous cell carcinomas of the head and neck: population-based outcomes from a Canadian province MS Tiwana, J Wu, J Hay, F Wong, W Cheung, RA Olson Oral oncology 50 (7), 651-656, 2014 | 107 | 2014 |
| Eligibility of metastatic pancreatic cancer patients for first-line palliative intent nab-paclitaxel plus gemcitabine versus FOLFIRINOX RD Peixoto, M Ho, DJ Renouf, HJ Lim, S Gill, JY Ruan, WY Cheung American journal of clinical oncology 40 (5), 507-511, 2017 | 88 | 2017 |
| Real-world comparative effectiveness of nab-paclitaxel plus gemcitabine versus FOLFIRINOX in advanced pancreatic cancer: a systematic review EG Chiorean, WY Cheung, G Giordano, G Kim, SE Al-Batran Therapeutic advances in medical oncology 11, 1758835919850367, 2019 | 81 | 2019 |
| A real-world comparison of FOLFIRINOX, gemcitabine plus nab-paclitaxel, and gemcitabine in advanced pancreatic cancers Y Wang, P Camateros, WY Cheung Journal of gastrointestinal cancer 50, 62-68, 2019 | 81 | 2019 |
| Genetic variations in esophageal cancer risk and prognosis WY Cheung, G Liu Gastroenterology Clinics of North America 38 (1), 75-91, 2009 | 80 | 2009 |
| Predictors of pathologic complete response after neoadjuvant treatment for rectal cancer: a multicenter study D Armstrong, S Raissouni, JP Hiller, J Mercer, E Powell, A MacLean, ... Clinical colorectal cancer 14 (4), 291-295, 2015 | 74 | 2015 |
| The cost and cost trajectory of whole‐genome analysis guiding treatment of patients with advanced cancers D Weymann, J Laskin, R Roscoe, KA Schrader, S Chia, S Yip, ... Molecular genetics & genomic medicine 5 (3), 251-260, 2017 | 68 | 2017 |
| Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictive and prognostic markers in patients with locally advanced rectal cancer treated with neoadjuvant … S Dudani, H Marginean, PA Tang, JG Monzon, S Raissouni, TR Asmis, ... BMC cancer 19, 1-9, 2019 | 61 | 2019 |
